Erratum To: NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Is Enhanced by Tamoxifen in HER2/neu Non-Amplified, but Not HER2/neu-amplified, Breast Cancer Cells

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-016-1903-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

HER2/neu Antisense Therapeutics in Human Breast Cancer

2002English

Hedgehog Acyltransferase as a Target in Estrogen Receptor Positive, HER2 Amplified, and Tamoxifen Resistant Breast Cancer Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Her2/Neu Protein Expression in Colorectal Cancer

Journal of Evolution of Medical and Dental Sciences
2019English

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

Activating Mutations in HER2 : Neu Opportunities and Neu Challenges

Cancer Discovery
Oncology
2013English

Effects of CSK Homologous Kinase Overexpression on HER2/Neu-Mediated Signal Transduction Pathways in Breast Cancer Cells

2004English

Degradation of HER2/neu by ANT2 shRNA Suppresses Migration and Invasiveness of Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Lapatinib Enhances Trastuzumab-Mediated Antibody-Dependent Cellular Cytotoxicity via Upregulation of HER2 in Malignant Mesothelioma Cells

Oncology Reports
MedicineCancer ResearchOncology
2015English

HER2 (ERBB2; Neu); Transferrin Receptor

Science-Business eXchange
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy